Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -9-MTH group results

Feb 2 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              216.43              224.98           281.50     
                   (-3.8 pct)          (+1.5 pct)       (-3.0 pct)   
  Operating           26.56               22.72            30.50     
                   (+16.9 pct)         (-8.5 pct)       (+5.6 pct)   
  Recurring           31.38               29.10            36.50     
                   (+7.8 pct)          (-5.8 pct)       (-0.7 pct)   
  Net                 23.67               18.71            27.50     
                   (+26.5 pct)         (-4.8 pct)       (+22.4 pct)  
  EPS              296.21 yen          230.74 yen       344.15 yen   
  EPS Diluted      296.01 yen          230.61 yen                    
  Ann Div                              100.00 yen       110.00 yen   
  -Q2 div           50.00 yen           50.00 yen                    
  -Q4 div                               50.00 yen        60.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news